XML 67 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Stockholders’ Equity [Line Items]    
Schedule of Warrants to Purchase Common Stock Outstanding

The number of shares of the Company’s common stock outstanding immediately following the consummation of the Merger was:

 

   Shares 
Common stock of ACAB, net of redemptions   7,033 
ACAB Founder Shares, less of forfeitures and transfers   126,076 
New Abpro shares issued to PIPE investors   112,247 
New Abpro shares issued to service providers   42,762 
New Abpro shares issued in Merger to Legacy Abpro stockholders   1,304,107 
New Abpro shares transferred to investors   72,285 
New Abpro shares issued to settle the promissory note with executive   20,000 
Total shares of common stock outstanding immediately after Merger   1,684,510 

The number of shares of the Company’s common stock outstanding immediately following the consummation of the Merger was:

 

   Shares 
Common stock of ACAB, net of redemptions   7,033 
ACAB Founder Shares, less of forfeitures and transfers   126,076 
New Abpro shares issued to PIPE investors   112,247 
New Abpro shares issued to service providers   42,762 
New Abpro shares issued in Merger to Legacy Abpro stockholders   1,304,107 
New Abpro shares transferred to investors   72,285 
New Abpro shares issued to settle the promissory note with executive   20,000 
Total shares of common stock outstanding immediately after Merger   1,684,510 
Schedule of Common Stock Warrant Activity  

The following table sets forth the common stock warrant activity for the year ended December 31, 2024:

 

   Legacy
Abpro
Common		         
   Stock
Warrants		   Private
Warrants		   Public
Warrants		 
Outstanding as of December 31, 2023   2,034    
-
    
-
 
Expired at the Merger   (2,034)   
-
    
-
 
Common stock warrants of ACAB acquired in Merger   
-
    461,667    500,000 
Outstanding as of December 31, 2024   
-
    461,667    500,000 
Warrant [Member]    
Stockholders’ Equity [Line Items]    
Schedule of Warrants to Purchase Common Stock Outstanding

The following presents information about warrants to purchase common stock outstanding as of June 30, 2025:

 

       Weighted-   Average
       Average   Remaining
   Shares   Exercise Price   Contractual Life
Warrants   990,000   $114.60   4.5 years

The following presents information about warrants to purchase common stock outstanding as of December 31, 2024:

 

   Shares   Weighted-
Average
Exercise
Price		   Average Remaining
Contractual
Life
Warrants   961,667   $114.90   4.9 years